Benefits of PARP Inhibitor Use in Breast Cancer

JENNIFER LITTON, MD

Friday, January 11, 2019

Jennifer Litton, MD, Breast Medical Oncologist, MD Anderson Cancer Center, describes how PARP inhibitors compare to standard of care in breast cancer treatment.

Discussions >>

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.

Related Videos

The Nurse's Role in Facilitating Patient Enrollment in Clinical Trials

By: Katie Goodman, RN, BSN, CCRP

Disparities Exist in Delivering Innovative Cancer Therapies

By: John Sweetenham, MD, FACP, FRCP

The Future of Telehealth in Cancer Care

By: Allen Lichter, MD, FASCO

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions